The DIA Pharmacovigilance and Risk Management Strategies conference 2017, at the Mandarin Oriental Washington DC, is all about innovation across the lifecycle of biopharmaceutical products, including new therapeutic approaches that are changing lives by speeding up processes and engaging patients more in drug development and the regulatory landscape. At MyMeds&Me, we’re particularly looking forward to Session 4: Safety Data rEvolution on Day 1, 3:30-5:00pm where we’ll hear how automation and AI can streamline pharmacovigilance analysis.
The MyMeds&Me team will be presenting at booth 25 where we’re demonstrating the latest, Post Approval version of our Reportum® adverse event and product quality capture solution.
Register today at http://bit.ly/2iFgsb6 and come and join us. We look forward to meeting you and learning more about your plans to transform your pharmacovigilance processes.